WO2016103423A1 - 骨接合用インプラントとその製造方法 - Google Patents
骨接合用インプラントとその製造方法 Download PDFInfo
- Publication number
- WO2016103423A1 WO2016103423A1 PCT/JP2014/084403 JP2014084403W WO2016103423A1 WO 2016103423 A1 WO2016103423 A1 WO 2016103423A1 JP 2014084403 W JP2014084403 W JP 2014084403W WO 2016103423 A1 WO2016103423 A1 WO 2016103423A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- implant
- anodized film
- osteosynthesis
- pores
- less
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30838—Microstructures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/3092—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30971—Laminates, i.e. layered products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/50—Prostheses not implantable in the body
- A61F2/76—Means for assembling, fitting or testing prostheses, e.g. for measuring or balancing, e.g. alignment means
- A61F2002/7615—Measuring means
- A61F2002/769—Displaying measured values
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00035—Other metals or alloys
- A61F2310/00041—Magnesium or Mg-based alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00395—Coating or prosthesis-covering structure made of metals or of alloys
- A61F2310/00419—Other metals
- A61F2310/00425—Coating made of magnesium or of Mg-based alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
- A61F2310/00598—Coating or prosthesis-covering structure made of compounds based on metal oxides or hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Definitions
- the present invention relates to an implant for osteosynthesis and a manufacturing method thereof.
- a biodegradable implant material in which a porous film is formed on a base material made of a magnesium alloy to enhance in-vivo corrosion resistance (see, for example, Patent Document 1).
- One of the functions required for osteosynthesis implants is osteoconductivity. It is known that osteoconductivity is related to the hydrophilicity of the surface of the implant for osteosynthesis, and that the osteoconductivity decreases when the hydrophilicity decreases.
- a physical method such as sandblasting or a chemical method such as etching with an acid has been proposed (for example, see Patent Document 2).
- the present invention relates to an implant for osteosynthesis that has high osteoconductivity at low cost and can be firmly bonded to bone in a short time after implantation without performing a hydrophilic treatment on the surface, and a method for producing the same.
- the purpose is to provide.
- One aspect of the present invention includes a base material made of magnesium or a magnesium alloy, and a porous anodic oxide film formed on the surface of the base material. Due to the size and distribution of the pores formed at the time of generation, the osteosynthesis implant has an outer surface that prevents water from entering the pores while structurally maintaining hydrophilicity.
- the bone conductivity is maintained, and the structure prevents the water from entering the pores.
- the formation and mixing of carbides due to the bond between water remaining inside and surrounding carbon atoms can be prevented, and the decrease in osteoconductivity can be prevented.
- Such a property is structurally imparted by the size and distribution of pores formed during the generation of the anodized film by anodizing treatment, so there is no need to perform hydrophilic recovery treatment such as sandblasting or etching, It can be firmly bonded to the bone after implantation by high osteoconductivity without mixing any residue at low cost.
- the outer surface of the anodic oxide film may have a surface structure superior to the Cassie-Baxter model over the Wenzel model.
- the outer surface and the liquid surface are slightly rough and rough, and the liquid surface is in contact with a large area, so that it has high hydrophilicity.
- the state in which the water droplet and the outer surface are in point contact is dominant due to the presence of many pores into which the water droplet cannot enter.
- invasion of the water drop into a pore can be prevented, the residue of a carbide
- 1.81 or less may be sufficient as the ratio of the opening area of the said pore in the said outer surface of the said anodic oxide film, and the area of an other than that part.
- the Cassie-Baxter model can be made dominant on the outer surface of the anodized film.
- 1 or less may be sufficient as the ratio of the opening area of the said pore in the said outer surface of the said anodic oxide film, and the area of the other part.
- the thickness of the anodic oxide film may be 1 to 5 ⁇ m, and the average pore diameter of the pores opening on the outer surface may be 5 ⁇ m or less.
- the anodized film may have a film thickness of 1 to 5 ⁇ m, and the average pore diameter of the pores opened on the outer surface may be 1 ⁇ m or less.
- 1 micrometer or less of the macro surface roughness of the said outer surface of the said anodized film may be sufficient.
- the electrolytic solution contains 0.1 mol / L or less of phosphoric acid, contains ammonia or ammonium ions at 0.2 mol / L, does not contain fluorine or chlorine, and has a pH of 9 to 13.
- the anodized film may be formed by anodic oxidation treatment in which the base material made of magnesium or a magnesium alloy is immersed and energized.
- Another aspect of the present invention contains 0.1 mol / L or less of phosphoric acid, contains ammonia or ammonium ions at 0.2 mol / L, does not contain fluorine or chlorine, and has a pH of 9 to 13.
- This is a method for producing an osteosynthesis implant in which a base material made of magnesium or a magnesium alloy is immersed in a certain electrolytic solution and subjected to an anodizing treatment for energization.
- an osteosynthesis implant 1 for osteosynthesis according to an embodiment of the present invention will be described below with reference to the drawings.
- an osteosynthesis implant 1 includes a base material 2 made of magnesium or a magnesium alloy, and a porous anodic oxide film 3 formed on the surface of the base material 2. I have.
- the anodized film 3 is structurally water (hereinafter referred to as water droplets) into the pores 3a while maintaining hydrophilicity due to the size and distribution of the pores 3a formed when the anodized film 3 is formed by anodization. ) It has an outer surface that prevents W from entering. Specifically, the macro structure of the anodized film 3 produced in the anodizing process is smoothed. That is, the anodized film 3 has an outer surface with a macro roughness suppressed to 1 ⁇ m or less.
- the macro roughness is a geometric shape having a frequency lower than the pores associated with anodization and a frequency higher than the geometric deviation of the anodized product.
- the anodized film 3 controls the microstructure of the anodized film 3 produced in the anodizing process, and has a surface structure of the outer surface that reduces the adsorption of moisture into the pores 3a while maintaining hydrophilicity.
- the ratio of the opening area of the pores 3a that open to the outer surface of the anodized film 3 and the area of the other portion is set to be 1.81 or less.
- the outer surface of the anodized film 3 of the bone implant 1 according to the present embodiment is such that the ratio of the opening area of the pores 3a opening to the outer surface and the area of the other part is 1.81 or less. Therefore, the Cassie-Baxter model shown in FIG. 2B is more dominant than the so-called Wenzel model shown in FIG. 2A.
- the microscopically rough outer surface and the liquid surface due to the pores 3a on the surface are apparently in contact with each other over a large area, so that the water droplet W
- the water droplets W and the outer surface are in point contact with each other due to the presence of a large number of pores 3a that cannot enter. For this reason, it is difficult for moisture to enter the pores 3a on the outer surface of the bone implant 1. Therefore, in the storage period until implantation in the living body, it is difficult for carbon in the air to be taken in, and the binding between moisture and carbon. It is possible to prevent the formation of carbides due to.
- the etched carbon pure titanium (sample A) having a mass concentration of 17% is 70% in 2 weeks after implantation in a rat and 90% in 4 weeks after bone implantation. It becomes.
- pure titanium (sample B) having a mass concentration of carbon of 64% has an osteosynthesis rate of 30% in 2 weeks after implantation and 60% in 4 weeks.
- the bone bonding rate of pure titanium having a carbon mass concentration of 17% is 70% at 2 weeks after implantation in rats and 90% at 4 weeks. %.
- the bone bonding rate of pure titanium with a carbon mass concentration of 64% is 30% after 2 weeks of implantation in rats and 60% after 4 weeks, so when interpolated, it is 45% after 3 weeks of implantation.
- the proportional relationship between the bone bonding rate and the carbon mass concentration at the time of 3 weeks after implantation is expressed by the following equation (1).
- Y ⁇ 0.76X + 94 (1)
- Y is the bone bonding rate at 3 weeks after implantation
- X is the carbon mass concentration.
- the carbon mass concentration is about 5.26%, that is, 6% or less. Therefore, when the surface carbon mass concentration is 6% or less, it is possible to maintain the surface osteoconductivity so that early rehabilitation can be started.
- the osteosynthesis implant 1 according to the present embodiment when the osteosynthesis implant 1 according to the present embodiment is implanted in the bone tissue, the outer surface of the anodized film 3 comes into contact with the body fluid, and biodegradation is started.
- the implant 1 for osteosynthesis according to the present embodiment prevents the formation of carbides on the surface and has high hydrophilicity, and thus has high osteoconductivity, and has an early relationship with the surrounding bone tissue. There is an advantage that it can be joined firmly and firmly. Thereafter, until the anodized film 3 and the base material 2 disappear due to biodegradation, the osteosynthesis implant 1 maintains the mechanical strength and can stably complete the healing of the surrounding bone tissue.
- the ratio of the opening area of the pores 3a that open to the outer surface and the area of the other part is set to be 1.81 or less, thereby making it more effective than the Wenzel model.
- the structure is configured so that the Cassie-Baxter model is dominant, the ratio is preferably 1 or less.
- the angle of the opening of the pore 3a on the outer surface is smaller than the water droplet contact angle.
- the contact angle of the magnesium anodized film 3 is about 30 °. Therefore, if the thickness of the anodized film 3 is 1 to 5 ⁇ m, more preferably 2 to 5 ⁇ m, and the opening diameter of the pores 3a is 5 ⁇ m or less, more preferably 1 ⁇ m or less, the condition is satisfied and The Zell model and the Cassie-Baxter model can coexist, making it difficult for moisture to enter the pores 3a. Moreover, even if the thickness of the film varies, it is possible to more reliably prevent water droplets from entering the pores 3a.
- the manufacturing method of the osteosynthesis implant 1 which concerns on this embodiment is demonstrated.
- 0.0001 mol / L or more, 5 mol / L or less, preferably 0.1 mol / L or less of phosphoric acid or phosphate radical is contained, and ammonia or ammonium Substrate 2 made of magnesium or a magnesium alloy in an electrolytic solution containing ions of 0.01 mol / L or more and 5 mol / L or less, preferably 0.2 mol / L, does not contain fluorine and chlorine, and has a pH of 9 to 13.
- Anodizing is performed by immersing and energizing.
- the electrolyte temperature at the time of electricity supply is controlled to 5 degreeC or more and 50 degrees C or less.
- each temperature of the immersion treatment solution is effective even if it is kept at room temperature, but if it is immersed at a temperature of 40 ° C. to 80 ° C., the effect of dissolving and removing impurities is expected more.
- the anodizing treatment is performed by connecting a power source between the base material 2 immersed in the electrolytic solution as an anode and the cathode material similarly immersed.
- the power source to be used is not particularly limited, and either a DC power source or an AC power source can be used, but it is preferable to use a DC power source.
- the cathode material is not particularly limited, and for example, a stainless material can be preferably used.
- the surface area of the cathode is preferably larger than the surface area of the substrate 2 to be anodized.
- the current density on the surface of the substrate 2 is 20 A / dm 2 or more.
- the energization time is 10 to 1000 seconds.
- the applied voltage at the start of energization is low, the applied voltage increases with time.
- the final voltage of the applied voltage at the end of energization is 350 V or more.
- FIG. 5A is an electron micrograph of the outer surface of the osteosynthesis implant 1 manufactured by the first example of the manufacturing method according to the present embodiment
- FIG. 5B is a microscope showing a tomographic image extending from the anodized film 3 to the base material 2.
- the first example is manufactured by setting the concentration of phosphoric acid to 0.05 mol / L, the current density on the surface of the base material 2 to 20 A / dm 2 , and the final voltage to be applied at the end of energization to 400 V. It is a thing. According to this, the mass concentration of carbon atoms on the outer surface of the anodized film 3 was 5.05%.
- FIG. 6A is an electron micrograph of the outer surface of the implant 1 for osteosynthesis manufactured by the second example of the manufacturing method according to the present embodiment
- FIG. 6B is an electron showing a tomographic image from the anodized film 3 to the base material 2.
- the second example is manufactured by setting the concentration of phosphoric acid to 0.05 mol / L, the current density on the surface of the substrate 2 to 30 A / dm 2 , and the final voltage to be applied at the end of energization to 350 V. It is a thing. According to this, the mass concentration of carbon atoms on the outer surface of the anodized film 3 was 4.19%.
- FIG. 7A shows an electron micrograph of the outer surface of the anodized film 3 having a surface structure in which the Wenzel model is dominant, on which carbon is not adsorbed.
- FIG. 7B shows an electron micrograph showing a tomographic image over a wide range
- FIG. 7C shows an electron micrograph of the outer surface on which carbon is adsorbed.
- the mass concentration of carbon atoms on the outer surface of the anodized film 3 was 39.47%.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dispersion Chemistry (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
このようにすることで、外表面に水滴が付着すると、気孔の分布によって、ミクロ的に凹凸が多く粗い外表面と液面がとがみかけ上、広い面積で接するために高い親水性を有する一方で、水滴が入り込めない多数の気孔の存在によって水滴と外表面とが点接触している状態が支配的となる。これにより、気孔内への水滴の侵入を防止して、炭化物の残留を防止し、骨伝導能を向上することができる。
このようにすることで、陽極酸化皮膜の外表面においてカシー・バクスターモデルを支配的にすることができる。
また、上記態様においては、前記陽極酸化皮膜の前記外表面における前記気孔の開口面積と、それ以外の部分の面積との比率が1以下であってもよい。
このようにすることで、気孔内への水滴の侵入をより確実に防止することができる。
このようにすることで、陽極酸化皮膜の厚さが1~5μmの場合に、カシー・バクスターモデルとワンゼルモデルとが共存することになり、気孔内への水分の残留を防止して、炭化物の混入を防止することができる。
このようにすることで、陽極酸化皮膜の外表面における見かけ上の濡れ性を低下させることができる。
本実施形態に係る骨接合用インプラント1は、図1に示されるように、マグネシウムまたはマグネシウム合金からなる基材2と、該基材2の表面に形成された多孔性の陽極酸化皮膜3とを備えている。
具体的には、陽極酸化処理において生成される陽極酸化皮膜3のマクロ構造を平滑化している。すなわち、陽極酸化皮膜3は、マクロ粗さを1μm以下に抑えた外表面を有している。
ここで、マクロ粗さとは、陽極酸化に伴う気孔よりも低い周波数をもち、被陽極酸化品の幾何偏差よりも高い周波数をもつ幾何形状である。
本実施形態に係る骨接合用インプラント1の陽極酸化皮膜3の外表面は、該外表面に開口する気孔3aの開口面積と、それ以外の部分の面積との比率が1.81以下となるように設定されているので、図2Aに示される、いわゆるウェンゼル(Wenzel)モデルよりも図2Bに示される、カシー・バクスター(Cassie-Baxter)モデルが支配的となる。
このため、骨接合用インプラント1の外表面の気孔3a内には水分が入り込み難いので、生体内に埋植するまでの保存期間において、空気中の炭素が取り込まれ難く、水分と炭素との結合による炭化物の生成を防止することができる。
ここで、Yは埋植後3週間の時点での骨結合率、Xは炭素質量濃度である。
上式(1)により、埋植後3週間の時点での骨結合率が90%の場合には、炭素質量濃度が約5.26%、すなわち6%以下となる。したがって、表面の炭素質量濃度が6%以下の場合に、早期リハビリを開始できるような表面の骨伝導能を保持することができる。
したがって、陽極酸化皮膜3の厚さが1~5μm、より好ましくは2~5μmであり、かつ、気孔3aの開口径が5μm以下、より好ましくは1μm以下であれば、条件が満たされて、ウェンゼルモデルとカシー・バクスターモデルとを共存させることができ、気孔3a内に水分を入り込み難くすることができる。また、皮膜の厚みにばらつきが生じても、より確実に気孔3a内への水滴の進入を防止することができる。
本実施形態に係る骨接合用インプラント1を製造するには、0.0001mol/L以上、5mol/L以下、好ましくは、0.1mol/L以下のリン酸またはリン酸根を含有し、アンモニアまたはアンモニウムイオンが0.01mol/L以上、5mol/L以下、好ましくは、0.2mol/L含有し、フッ素および塩素を含有せず、pH9~13である電解液にマグネシウムまたはマグネシウム合金からなる基材2を浸漬して通電する陽極酸化を施す。
使用される電源は特に限定されるものではなく、直流電源でも交流電源でも使用可能であるが、直流電源を使用することが好ましい。
このようにすることで、単一の工程の陽極酸化処理により、上記構造の陽極酸化皮膜3を有する骨接合用インプラント1を製造することができる。
第1の実施例は、リン酸の濃度を0.05mol/Lとし、基材2の表面における電流密度を20A/dm2、通電を終了する際の印加電圧の最終到達電圧を400Vとして製造されたものである。
これによれば、陽極酸化皮膜3の外表面における炭素原子の質量濃度は5.05%であった。
第2の実施例は、リン酸の濃度を0.05mol/Lとし、基材2の表面における電流密度を30A/dm2、通電を終了する際の印加電圧の最終到達電圧を350Vとして製造されたものである。
これによれば、陽極酸化皮膜3の外表面における炭素原子の質量濃度は4.19%であった。
2 基材
3 陽極酸化皮膜
3a 気孔
Claims (9)
- マグネシウムまたはマグネシウム合金からなる基材と、
該基材の表面に形成された多孔性の陽極酸化皮膜とを備え、
該陽極酸化皮膜は、陽極酸化処理による該陽極酸化皮膜の生成時に形成された気孔の寸法および分布により、構造的に、親水性を維持しながら前記気孔内への水の侵入を防止する外表面を有する骨接合用インプラント。 - 前記陽極酸化皮膜の前記外表面が、ウェンゼルモデルよりもカシー・バクスターモデル優位な表面構造を有する請求項1に記載の骨接合用インプラント。
- 前記陽極酸化皮膜の前記外表面における前記気孔の開口面積と、それ以外の部分の面積との比率が1.81以下である請求項2に記載の骨接合用インプラント。
- 前記陽極酸化皮膜の前記外表面における前記気孔の開口面積と、それ以外の部分の面積との比率が1以下である請求項3に記載の骨接合用インプラント。
- 前記陽極酸化皮膜の膜厚が1~5μmであり、かつ前記外表面に開口する前記気孔の平均気孔径が5μm以下である請求項1から請求項4のいずれかに記載の骨接合用インプラント。
- 前記陽極酸化皮膜の膜厚が1~5μmであり、かつ前記外表面に開口する前記気孔の平均気孔径が1μm以下である請求項5に記載の骨接合用インプラント。
- 前記陽極酸化皮膜の前記外表面のマクロな表面粗さが1μm以下である請求項1から請求項6のいずれかに記載の骨接合用インプラント。
- 0.1mol/L以下のリン酸を含有し、アンモニアまたはアンモニウムイオンを0.2mol/L含有し、フッ素、塩素を含有せず、かつ、pH9~13である電解液にマグネシウムまたはマグネシウム合金からなる前記基材を浸漬して通電する陽極酸化処理により、前記陽極酸化皮膜を形成してなる請求項1から請求項7のいずれかに記載の骨接合用インプラント。
- 0.1mol/L以下のリン酸を含有し、アンモニアまたはアンモニウムイオンを0.2mol/L含有し、フッ素、塩素を含有せず、かつ、pH9~13である電解液にマグネシウムまたはマグネシウム合金からなる基材を浸漬して通電する陽極酸化処理を施す骨接合用インプラントの製造方法。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016565778A JP6438048B2 (ja) | 2014-12-25 | 2014-12-25 | 骨接合用インプラントとその製造方法 |
PCT/JP2014/084403 WO2016103423A1 (ja) | 2014-12-25 | 2014-12-25 | 骨接合用インプラントとその製造方法 |
CN201480083917.0A CN106999284A (zh) | 2014-12-25 | 2014-12-25 | 骨接合用植入物及其制造方法 |
DE112014007192.7T DE112014007192T5 (de) | 2014-12-25 | 2014-12-25 | Osteosynthetisches Implantat und Herstellungsverfahren hierfür |
US15/629,290 US20170281349A1 (en) | 2014-12-25 | 2017-06-21 | Osteosynthetic implant and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2014/084403 WO2016103423A1 (ja) | 2014-12-25 | 2014-12-25 | 骨接合用インプラントとその製造方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/629,290 Continuation US20170281349A1 (en) | 2014-12-25 | 2017-06-21 | Osteosynthetic implant and manufacturing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016103423A1 true WO2016103423A1 (ja) | 2016-06-30 |
Family
ID=56149516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2014/084403 WO2016103423A1 (ja) | 2014-12-25 | 2014-12-25 | 骨接合用インプラントとその製造方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20170281349A1 (ja) |
JP (1) | JP6438048B2 (ja) |
CN (1) | CN106999284A (ja) |
DE (1) | DE112014007192T5 (ja) |
WO (1) | WO2016103423A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3011979A4 (en) * | 2013-06-18 | 2017-02-15 | Olympus Corporation | Implant for living organisms |
HUE042725T2 (hu) * | 2017-05-18 | 2019-07-29 | Grob Gmbh & Co Kg | Eljárás és készülék bevont felületek minõségének vizsgálatára |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008534126A (ja) * | 2005-03-29 | 2008-08-28 | ウォーソー・オーソペディック・インコーポレーテッド | ナノチューブを包含するインプラントおよびその製造方法 |
JP2011072617A (ja) * | 2009-09-30 | 2011-04-14 | Olympus Corp | 移植材とその製造方法 |
WO2013021913A1 (ja) * | 2011-08-05 | 2013-02-14 | 株式会社メディカルユーアンドエイ | 骨接合材 |
JP5424865B2 (ja) * | 2006-03-24 | 2014-02-26 | ボストン サイエンティフィック リミテッド | 制御された治療薬送達のためのナノ多孔性コーティングを有する医療器具 |
JP2014136008A (ja) * | 2013-01-16 | 2014-07-28 | Olympus Corp | インプラント |
JP2014530058A (ja) * | 2011-09-29 | 2014-11-17 | 上海微▲創▼医▲療▼器械(集▲團▼)有限公司 | 介入医療機器およびその製造方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7291178B2 (en) * | 2001-05-29 | 2007-11-06 | Mediteam Dental Ab | Modified oxide |
JP4367838B2 (ja) * | 2002-03-25 | 2009-11-18 | 堀金属表面処理工業株式会社 | 導電性陽極酸化皮膜を表面に有するマグネシウム又はマグネシウム合金製品及びその製造方法 |
JP4714945B2 (ja) * | 2003-08-19 | 2011-07-06 | 岡山県 | マグネシウム又はマグネシウム合金からなる製品の製造方法 |
JP2009267337A (ja) * | 2007-09-28 | 2009-11-12 | Fujifilm Corp | 太陽電池 |
CN101560686B (zh) * | 2009-04-28 | 2010-09-15 | 先健科技(深圳)有限公司 | 人体可吸收镁合金材料处理方法及镁合金复合层 |
WO2012102205A1 (ja) * | 2011-01-24 | 2012-08-02 | オリンパス株式会社 | 生分解性移植材およびその製造方法 |
JP5846591B2 (ja) * | 2011-07-27 | 2016-01-20 | フラウンホッファー−ゲゼルシャフト・ツァー・フォデラング・デル・アンゲワンテン・フォーシュング・エー.ファウ. | インプラント |
CN102747406B (zh) * | 2012-07-20 | 2014-12-03 | 重庆大学 | 镁合金阳极氧化电解液及对镁合金表面处理的方法 |
EP3011979A4 (en) * | 2013-06-18 | 2017-02-15 | Olympus Corporation | Implant for living organisms |
-
2014
- 2014-12-25 DE DE112014007192.7T patent/DE112014007192T5/de not_active Withdrawn
- 2014-12-25 WO PCT/JP2014/084403 patent/WO2016103423A1/ja active Application Filing
- 2014-12-25 JP JP2016565778A patent/JP6438048B2/ja active Active
- 2014-12-25 CN CN201480083917.0A patent/CN106999284A/zh active Pending
-
2017
- 2017-06-21 US US15/629,290 patent/US20170281349A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008534126A (ja) * | 2005-03-29 | 2008-08-28 | ウォーソー・オーソペディック・インコーポレーテッド | ナノチューブを包含するインプラントおよびその製造方法 |
JP5424865B2 (ja) * | 2006-03-24 | 2014-02-26 | ボストン サイエンティフィック リミテッド | 制御された治療薬送達のためのナノ多孔性コーティングを有する医療器具 |
JP2011072617A (ja) * | 2009-09-30 | 2011-04-14 | Olympus Corp | 移植材とその製造方法 |
WO2013021913A1 (ja) * | 2011-08-05 | 2013-02-14 | 株式会社メディカルユーアンドエイ | 骨接合材 |
JP2014530058A (ja) * | 2011-09-29 | 2014-11-17 | 上海微▲創▼医▲療▼器械(集▲團▼)有限公司 | 介入医療機器およびその製造方法 |
JP2014136008A (ja) * | 2013-01-16 | 2014-07-28 | Olympus Corp | インプラント |
Also Published As
Publication number | Publication date |
---|---|
JPWO2016103423A1 (ja) | 2017-09-28 |
US20170281349A1 (en) | 2017-10-05 |
DE112014007192T5 (de) | 2017-08-24 |
JP6438048B2 (ja) | 2018-12-12 |
CN106999284A (zh) | 2017-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2994292C (en) | Surface treatment for an implant surface | |
JP6027894B2 (ja) | 生分解性移植材およびその製造方法 | |
WO2015186390A1 (ja) | 骨接合用インプラント | |
US20170218522A1 (en) | Metallic workpiece of titanium and/or a titanium alloy and/or nickel-titanium alloys and also nitinol with a porous surface and production process | |
KR101283780B1 (ko) | 타이타늄 임플란트 및 그의 제조 방법 | |
US10980914B2 (en) | Antibacterial biological implant | |
JP6438048B2 (ja) | 骨接合用インプラントとその製造方法 | |
JP6253528B2 (ja) | インプラント | |
WO2007069532A1 (ja) | 骨親和性インプラント及びその製造方法 | |
US10940234B2 (en) | Method for producing antibacterial biological implant | |
TWI462757B (zh) | 鈦人工植體表面處理方法 | |
JPH0731627A (ja) | インプラントとその製造方法 | |
WO2015186388A1 (ja) | インプラントとその製造方法 | |
KR101892448B1 (ko) | 임플란트용 멤브레인 및 그 제조방법 | |
KR102109949B1 (ko) | 염화물과 펄스 전원을 이용한 티타늄 임플란트 재료의 표면 처리 방법 및 그로부터 표면 처리된 티타늄 임플란트 | |
JPH0747115A (ja) | インプラント及びその製造方法 | |
TW201315846A (zh) | 鈦金屬植入物表面處理方法及其鈦金屬植入物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14909030 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2016565778 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 112014007192 Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14909030 Country of ref document: EP Kind code of ref document: A1 |